| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM | 2 | |
| Valproic Acid | ACTIVE INGREDIENT | 614OI1Z5WI | These highlights do not include all the information needed to use Valproic Acid Capsules safely and effectively. See full prescribing information for Valproic Acid Capsules. Valproic Acid Capsules, USP for oral use USP Initial U.S. Approval: 1978 | 1 | |
| Valproic Acid | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Valproic Acid Capsules safely and effectively. See full prescribing information for Valproic Acid Capsules. Valproic Acid Capsules, USP for oral use USP Initial U.S. Approval: 1978 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex sodium extended-release tablets for oral use Initial U.S. Approval: 2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Divalproex Sodium Delayed Release Tablets safely and effectively. See full prescribing information for Divalproex Sodium Delayed Release Tablets. Divalproex Sodium Delayed Release Tablets USP for Oral use. Initial U.S. Approval: 1983 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 1983 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use DIVALPROEX Sodium Delayed-Release Tablets, USP safely and effectively. See full prescribing information for DIVALPROEX Sodium Delayed-Release Tablets, USP DIVALPROEX Sodium Delayed-Release Tablets, USP for Oral use Initial U.S. Approval: 1983 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex sodium extended-release tablets for oral use Initial U.S. Approval: 2000 | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 2000 | 2 | |
| valproic acid | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Valproic Acid Capsules, USP safely and effectively. See full prescribing information for Valproic Acid Capsules, USP. Valproic Acid Capsules, USP for Oral use Initial U.S. Approval: 1978 | 1 | |
| valproic acid | ACTIVE INGREDIENT | 614OI1Z5WI | These highlights do not include all the information needed to use Valproic Acid Capsules, USP safely and effectively. See full prescribing information for Valproic Acid Capsules, USP. Valproic Acid Capsules, USP for Oral use Initial U.S. Approval: 1978 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Depakote ER safely and effectively. See full prescribing information for Depakote ER. Depakote ER (divalproex sodium) Tablet, Extended Release for Oral use Initial U.S. Approval: 2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | Divalproex Sodium Delayed Release Tablets USP | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP . D ivalproex Sodium Delayed-Release Tablets, USP for Oral Use Initial U.S. Approval: 1983 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE TABLETS | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP . D ivalproex Sodium Delayed-Release Tablets, USP for Oral Use Initial U.S. Approval: 1983 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex Sodium Extended-release Tablets, USP for oral use Initial U.S. Approval: 2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | Valproic Acid Liquid Capsules | 1 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | Valproic Acid Liquid Capsules | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | Divalproex Sodium Delayed-Release Tablets, USP Rx only | 1 | |
| valproic acid | ACTIVE MOIETY | 614OI1Z5WI | Valproic Acid | 1 | |
| valproic acid | ACTIVE INGREDIENT | 614OI1Z5WI | Valproic Acid | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Depakote ER safely and effectively. See full prescribing information for Depakote ER. Depakote ER (divalproex sodium) Tablet, Extended Release for Oral use Initial U.S. Approval: 2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | Divalproex Sodium Delayed-Release Tablets USP 125 mg, 250 mg and 500 mg | 1 | |
| Valproic Acid | ACTIVE MOIETY | 614OI1Z5WI | Divalproex Sodium Delayed-Release Tablets, USP | 2 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets for oral administration. Divalproex Sodium Extended-release Tablets Initial U.S. Approval: 2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Divalproex sodium extended release tablets safely and effectively.See full prescribing information for divalproex sodium extended release tablets. Divalproex Sodium Extended Release Tablets for Oral use. Initial U.S. approval:2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use Depakote ER safely and effectively. See full prescribing information for Depakote ER. Depakote ER (divalproex sodium) Tablet, Extended Release for Oral use Initial U.S. Approval: 2000 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | 9fb17714-bdb1-4bfa-bc04-d9c011604cde | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | f738ddad-fef0-43cb-b791-b046fdcec311 | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | Valproic Acid Liquid Capsules | 1 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | Valproic Acid Liquid Capsules | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | Valproic Acid Liquid Capsules | 1 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | Valproic Acid Liquid Capsules | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE TABLETS | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE TABLETS | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE TABLETS USP 7439 7440 7441 Rx only | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex sodium extended-release tablets for oral administration Initial U.S. Approval: 2000 | 2 | |
| Valproic acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP | 1 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3983 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKOTE (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3197 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKOTE ER (DIVALPROEX SODIUM) TABLET, EXTENDED RELEASE [ABBVIE INC.] | 1571 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKOTE SPRINKLES (DIVALPROEX SODIUM) CAPSULE [ABBVIE INC.] | 1547 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | DEPAKENE (VALPROIC ACID) SOLUTION DEPAKENE (VALPROIC ACID) CAPSULE, LIQUID FILLED [ABBVIE INC.] | 1541 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKENE (VALPROIC ACID) SOLUTION DEPAKENE (VALPROIC ACID) CAPSULE, LIQUID FILLED [ABBVIE INC.] | 1541 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKOTE (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [ABBVIE INC.] | 1541 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPACON (VALPROATE SODIUM) INJECTION [ABBVIE INC.] | 1531 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1005 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM ER (DIVALPROEX SODIUM) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKOTE ER (DIVALPROEX SODIUM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM (DIVALPROEX SODIUM ) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 113 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM (DIVALPROEX SODIUM ) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 107 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [REMEDYREPACK INC. ] | 86 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM EXTENDED RELEASE (DIVALPROEX SODIUM) TABLET, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC] | 72 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 25 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED RELEASE (SPRINKLE) (DIVALPROEX SODIUM) CAPSULE [SANDOZ INC.] | 23 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE (DIVALPROEX SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS] | 21 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID CAPSULE, LIQUID FILLED [PLIVA INC.] | 19 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID CAPSULE, LIQUID FILLED [PLIVA INC.] | 19 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 16 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID SOLUTION [HI-TECH PHARMACAL CO., INC.] | 16 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID SOLUTION [HI-TECH PHARMACAL CO., INC.] | 16 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID SOLUTION [QUALITEST PHARMACEUTICALS] | 16 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID SOLUTION [QUALITEST PHARMACEUTICALS] | 16 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 15 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 14 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 14 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 14 | |
| valproic acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM CAPSULE [DR. REDDY'S LABORATORIES LTD] | 13 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] | 13 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 13 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM CAPSULE, COATED PELLETS [ZYDUS PHARMACEUTICALS (USA) INC.] | 12 | |
| valproic acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, EXTENDED RELEASE [DR. REDDY'S LABORATORIES LTD] | 12 | |
| valproic acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, EXTENDED RELEASE [DR. REDDY'S LABORATORIES LTD] | 12 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MAJOR PHARMACEUTICALS] | 12 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [MYLAN PHARMACEUTICAL INC.] | 11 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 11 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM EXTENDED-RELEASE (DIVALPROEX SODIUM) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL, INC.] | 10 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 10 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [UNICHEM PHARMACEUTICALS (USA), INC.] | 10 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 10 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 9 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 9 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 9 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [LUPIN PHARMACEUTICALS, INC.] | 8 | |
| Valproic Acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 8 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 7 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC (VALPROIC ACID) CAPSULE, LIQUID FILLED [ACTAVIS PHARMA, INC.] | 7 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC (VALPROIC ACID) CAPSULE, LIQUID FILLED [ACTAVIS PHARMA, INC.] | 7 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM CAPSULE, COATED PELLETS [CARDINAL HEALTH] | 6 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DELAYED-RELEASE (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [TWI PHARMACEUTICALS, INC.] | 6 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 6 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 6 | |
| valproic acid | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID CAPSULE [UPSHER-SMITH LABORATORIES, INC] | 6 | |
| valproic acid | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID CAPSULE [UPSHER-SMITH LABORATORIES, INC] | 6 | |
| Valproic Acid | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 6 | |
| Valproic Acid | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 6 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 6 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 6 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [CARDINAL HEALTH] | 5 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [CITRON PHARMA LLC] | 5 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 5 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROATE SODIUM INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 5 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC (VALPROIC ACID) CAPSULE, LIQUID FILLED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 5 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC (VALPROIC ACID) CAPSULE, LIQUID FILLED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 5 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [CARDINAL HEALTH] | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM EXTENDED RELEASE (DIVALPROEX SODIUM EXTENDED RELEASE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 4 | |
| Valproic Acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [CARDINAL HEALTH] | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [MYLAN INSTITUTIONAL INC.] | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, EXTENDED RELEASE [MAJOR PHARMACEUTICALS] | 4 | |
| VALPROIC ACID | ACTIVE INGREDIENT | 614OI1Z5WI | VALPROIC ACID SOLUTION [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | VALPROIC ACID SOLUTION [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 4 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DEPAKOTE (DIVALPROEX SODIUM) CAPSULE [CARDINAL HEALTH] | 3 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM CAPSULE, COATED PELLETS [AMERICAN HEALTH PACKAGING] | 3 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 3 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM EXTENDED-RELEASE (DIVALPROEX SODIUM) TABLET, EXTENDED RELEASE [CARDINAL HEALTH] | 3 | |
| VALPROIC ACID | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [UNIT DOSE SERVICES] | 3 | |
| Valproic Acid | ACTIVE MOIETY | 614OI1Z5WI | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 3 | |